Skip to main content

Table 2 Risk factors for bacteremia relating to access type and patient status

From: Catheter-related bloodstream infection in end-stage kidney disease: a Canadian narrative review

Country Risk factor Relative risk bacteremia Reference
Canada Prior access infection (vs. no prior access infection) 3.33 (95 %CI 2.1–5.2) [1]
Canada 30 days post-access type change (vs. continued HD modality) 1.56 (95 %CI 1.02–2.4) [1]
Canada Cuffed catheter (vs. AVF) 8.49 (95 %CI 3.0–23.8) [1]
Canada Uncuffed catheter (vs. AVF) 9.87 (95 %CI 3.5–28.2) [1]
  Catheter vs. AV Graft 7.6 (95 %CI 3.7–15.6) [19]
USA Chronic HD vs. non-HD patients 1.8 (95 %CI 1.1–3.1) [2]
France Immunosuppressive therapy (vs. no immunosuppressive treatment) 3.0 (95 %CI 1.0–6.1) [19]
France Prior access infection (vs. no prior access infection) 7.3 (95 %CI 3.2–16.4) [19]
Denmark S. aureus bacteremia with CVC (vs. none); general inpatient population not specific to ESRD 6.9 (95 %CI 2.8–17.0) [20]